Ginkgo Bioworks Holdings Inc vs JPMorgan Ultra Short Income ETF — how do they compare? Ginkgo Bioworks Holdings Inc trades at $7.51 (market cap $505.73M), while JPMorgan Ultra Short Income ETF trades at $50.45. Which is the better fit depends on your goals.
| DNA | JPST | |
|---|---|---|
Market Cap | $505.73M | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $16.14 | $50.78 |
52-Week Low | $5.48 | $50.40 |
Enterprise Value | $607.68M | — |
Trailing returns across standard periods
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →JPST is an actively managed ETF that invests in short-term, investment-grade fixed income securities. It aims to provide current income and capital preservation while maintaining high liquidity.
Read more on JPST →